Adjunct professor Carl Hansen featured in media for successful AbCellera IPO

Awards and recognition

Adjunct professor Carl Hansen featured in media for successful AbCellera IPO

Congratulations to Michael Smith Laboratories’ adjunct professor and former UBC Physics & Astronomy associate professor Carl Hansen for an extremely successful initial public offering of AbCellera, where he is the founding Chief Executive Officer. The company, now worth US $15-billion, utilizes an innovative assay technology that allows for rapid discovery of antibodies. The company spearheaded the development of an antibody treatment for COVID-19, which was recently granted by Health Canada for use in recently diagnosed, mild to moderate COVID-19 in high-risk patients.

This IPO sets the record for the biggest debut for a Canadian biotechnology company. 

Carl joined UBC in 2005, and left in the fall 2019 to pursue his commitment as Chief Executive Officer of AbCellera.

Media features on this success

More about AbCellera

Carl is also an alumnus of our Engineering Physics Program; the Program shared some highlights of Carl’s career through an Instagram post below.

Congratulations again Carl and the AbCellera team! 

 

 
 
 
 
 
View this post on Instagram
 
 
 
 
 
 
 
 
 
 
 

A post shared by UBC Engineering Physics (@ubcengineeringphysics)

This article was originally posted by the UBC Department of Physics and Astronomy